SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-18-012362
Filing Date
2018-08-20
Accepted
2018-08-20 16:52:35
Documents
73
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm 10-K/A 1496316
2 ex21-1.htm EX-21.1 8332
3 ex23-1.htm EX-23.1 5285
4 ex31-1.htm EX-31.1 19899
5 ex31-2.htm EX-31.2 19862
6 ex32-1.htm EX-32.1 8343
7 ex32-2.htm EX-32.2 8557
  Complete submission text file 0001493152-18-012362.txt   5995257

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE prph-20171231.xml EX-101.INS 941477
9 XBRL SCHEMA FILE prph-20171231.xsd EX-101.SCH 66390
10 XBRL CALCULATION FILE prph-20171231_cal.xml EX-101.CAL 81508
11 XBRL DEFINITION FILE prph-20171231_def.xml EX-101.DEF 236672
12 XBRL LABEL FILE prph-20171231_lab.xml EX-101.LAB 482354
13 XBRL PRESENTATION FILE prph-20171231_pre.xml EX-101.PRE 355605
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-21617 | Film No.: 181028705
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1